tiprankstipranks
Trending News
More News >

Kissei Pharmaceutical Reports Strong Sales Growth Amid Higher R&D Costs

Kissei Pharmaceutical Reports Strong Sales Growth Amid Higher R&D Costs

Kissei Pharmaceutical Co (JP:4547) has released an update.

Confident Investing Starts Here:

Kissei Pharmaceutical Co reported a 14.8% increase in net sales for the second quarter of Fiscal 2024, driven by its Pharmaceutical Business, despite a decline in operating profit due to rising R&D expenses. The company’s expansion of key and new products contributed significantly to the sales growth.

For further insights into JP:4547 stock, check out TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App